Mode
Text Size
Log in / Sign up
N/A N=424 Randomized Treatment

Powered Exoskeletons in Persons With SCI

Spinal Cord Injury

Enrolled (actual)
424
Serious AEs
8.9%
Results posted
Jun 2022
Primary outcome: Primary: Improvement on the MCS in All Randomized Participants — 12; 14 Participants — p=0.798

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ReWalk 6.0 (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Improvement on the MCS in All Randomized Participants
12; 14 0.798
PRIMARY
Improvement on the SCI-QOL Physical Medical Health Domain in All Randomized Participants
10; 11 0.935
SECONDARY
Total Body Fat Loss in All Randomized Participants
14; 16 0.829
SECONDARY
Improvement on the Mental Health Component Summary (MCS) in Participants Who Completed the 4 Month Intervention Phase.
12; 14 0.809
SECONDARY
Improvement on the SCI-QOL Physical Medical Health Domain in Participants Who Completed the 4 Month Intervention Phase.
10; 11 0.717
SECONDARY
Total Body Fat Loss in Participants Who Completed the 4 Month Intervention Phase.
14; 16 0.738
SECONDARY
Change in Mental Health Component Summary (MCS)
1.7; -0.3; 1.0; -1.0; -0.1; -1.8
SECONDARY
Change in SCI-QOL Physical Medical Health Domain
-4.4; -0.5; -5.9; -1.7; -6.9; -1.5
SECONDARY
Change in Total Body Fat
0.2; 0.3; 0.4; 0.1; 0.1; 0.1
SECONDARY
Change in SCI-QOL Social Participation Domain
1.9; -2.0; -0.2; -2.2; 4.1; -3.0
SECONDARY
Change in SCI-QOL Positive Emotional Constraints
0.1; -2.3; 1.7; -1.8; 2.6; -3.2
SECONDARY
Change in SCI-QOL Negative Emotional Constraints
-6.5; 3.6; -8.4; 1.1; -8.6; 1.5
SECONDARY
Change in SCI Functional Index (FI)
5.4; -5.8; 7.3; -4.5; 3.8; -8.6
SECONDARY
Change in Sleep Disturbance
-1.8; 2.1; -2.1; 1.6; -0.3; 1.3
SECONDARY
Change in Participant Impression of Severity
-0.2; 0.4; 0.0; 0.3; -0.1; 0.3
SECONDARY
Change in Companion Impression of Severity
0.0; 0.0; 0.2; 0.3; 0.2; 0.3
SECONDARY
Bowel Evacuation Time
14; 8; 10; 14; 10; 22
SECONDARY
Frequency of Bowel Evacuation Episodes
18; 23; 7; 9; 16; 16
SECONDARY
Manual/Digit Stimulation for Bowel Movements
11; 11; 1; 3; 5; 6
SECONDARY
Oral Medications for Bowel Movements
22; 33; 1; 3; 6; 2
SECONDARY
Enemas or Irrigations for Bowel Movements
30; 33; 1; 4; 4; 4
SECONDARY
Bowel Control
31; 43; 12; 11; 2; 1
SECONDARY
Stool Consistency
1; 4; 5; 10; 13; 14
SECONDARY
Change in Abdominal Fat Mass
57; 30; 93; 2; 67; 21
SECONDARY
Change in High Density Lipoprotein Cholesterol
0.8; -0.6; 1.3; 0.2; 0.7; -0.3
SECONDARY
Change in Low Density Lipoprotein Cholesterol
-2.9; 1.2; -0.6; -0.7; -2.4; 1.8
SECONDARY
Change in Total Cholesterol
2.9; 0.0; 2.6; 1.4; 4.8; 1.1
SECONDARY
Change in Triglycerides
3.9; 4.0; 3.0; 9.5; 14.9; -2.3
SECONDARY
Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
1.1; 0.1; 2.3; 0.1; 1.7; 0.3

Summary

Background Veterans with spinal cord injury (SCI) have many adverse secondary medical and quality of life (QOL) changes as a result of immobilization. Veterans with SCI who have completed rehabilitation after injury and are unable to ambulate receive a wheelchair as standard of care (SOC) for mobility. Powered exoskeletons are a technology that has recently become available as an alternate form of mobility by providing an external framework for support and computer controlled motorized hip and knee joints to assist with over ground ambulation.

Eligibility Criteria

Inclusion Criteria

  • Veterans or active duty military personnel who are at least 18 years of age;
  • Traumatic or non-traumatic SCI 6 months duration of SCI;
  • Wheelchair-user for indoor and outdoor mobility;
  • Anthropometric compatibility with the device:
  • Weight 15 degrees at the hip and/or > 10 degrees at the knee;
  • Limitations in ankle range of motion that cannot be adapted with an orthotic device (plantar flexion > 00);
  • Untreated or uncontrolled hypertension (systolic blood pressure >140 mmHg; diastolic blood pressure >90 mmHg);
  • Unresolved orthostatic hypotension (systolic blood pressure <90 mmHg; diastolic blood pressure <60 mmHg) as judged to be contraindicated by the Site Physician;
  • Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities;
  • Psychopathology documentation in the medical record or history that may conflict with study objectives; and/or
  • Pregnancy or women who plan to become pregnant during the study period.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02658656). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search